Literature DB >> 8386827

The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors.

D J Dumont1, G J Gradwohl, G H Fong, R Auerbach, M L Breitman.   

Abstract

We have cloned a 4.2-kb murine cDNA encoding the Tek receptor tyrosine kinase (RTK), which is expressed in endothelial cells and their progenitors. The 1122-residue protein contains an extracellular domain comprising three fibronectin type III repeats fused to two immunoglobulin-like loops that are in turn separated by three epidermal growth factor-like repeats. The association of these different structural motifs and their characteristic arrangement in the Tek extracellular domain has been reported for only one other RTK, Tie, an endothelial-specific RTK of human origin. We show here that Tek and Tie are encoded by distinct genes and that, together, these receptors define a new subfamily of RTKs. In addition, we demonstrate that the tek cDNA, when introduced into COS cells, encodes a product of 140 kDa and that this protein and/or tek transcripts are detectable in highly vascularized embryonic tissues and in some, but not all, cell lines of endothelial origin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386827

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

Authors:  Akiyoshi Uemura; Minetaro Ogawa; Masanori Hirashima; Takashi Fujiwara; Shinji Koyama; Hitoshi Takagi; Yoshihito Honda; Stanley J Wiegand; George D Yancopoulos; Shin-Ichi Nishikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

Authors:  P Lin; P Polverini; M Dewhirst; S Shan; P S Rao; K Peters
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival.

Authors:  Isao Hamaguchi; Tohru Morisada; Masaki Azuma; Kyoko Murakami; Madoka Kuramitsu; Takuo Mizukami; Kazuyuki Ohbo; Kazunari Yamaguchi; Yuichi Oike; Daniel J Dumont; Toshio Suda
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

Review 4.  Cardiovascular genomics: a current overview of in vivo and in vitro studies.

Authors:  Devi Mariappan; Johannes Winkler; Jürgen Hescheler; Agapios Sachinidis
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 5.  Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?

Authors:  J Laurén; Y Gunji; K Alitalo
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 6.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 7.  Tie-1: A potential target for anti-angiogenesis therapy.

Authors:  Ping Yang; Na Chen; Jing-Hui Jia; Xue-Jiao Gao; Shi-Han Li; Jing Cai; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

8.  Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.

Authors:  Mackenzie J Smith; Robert W Berger; Kanwal Minhas; Roger A Moorehead; Brenda L Coomber
Journal:  Int J Exp Pathol       Date:  2010-11-08       Impact factor: 1.925

9.  Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.

Authors:  Woo Sung Moon; Ho Sung Park; Ki Hoon Yu; Kyu Yun Jang; Myoung Jae Kang; Harry Park; Andrzej S Tarnawski
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

10.  Active stabilization of human endothelial nitric oxide synthase mRNA by hnRNP E1 protects against antisense RNA and microRNAs.

Authors:  J J David Ho; G Brett Robb; Sharon C Tai; Paul J Turgeon; Imtiaz A Mawji; H S Jeffrey Man; Philip A Marsden
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.